SCIENTIFIC PROGRAM
September 22nd, 2011 (thursday)

09.00-11.00 Symposium IV: Colorectal Cancer

Chairmen

  • Eduardo Díaz-Rubio
    (Hospital Clínico San Carlos, Madrid)
  • Enrique Aranda
    (Hospital Reina Sofía, Córdoba)

Speakers

  • Gabriel Capellá Munar
    Instituto Catalán de Oncología-IDIBELL, Barcelona
    Biology of Colorectal Cancer”
  • Jesús García-Foncillas
    CIMA, Pamplona
    ”Integration of anti-EGFR therapies with chemotherapy in metastatic colorectal cancer”
  • Eduardo Díaz-Rubio
    Hospital Clínico San Carlos, Madrid
    “Integration of anti-VEGF therapies with chemotherapy in metastatic colorectal cancer”
  • Josep Tabernero
    Hospital Valle de Hebrón, Barcelona
    “Novel agents in the treatment of colorectal cancer”

 

09.00-11.00 Symposium V: Breast cancer

Chairmen

  • Joaquín Arribas
  • Vall d'Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
  • Joan Albanell,
  • IMIM-Hospital del Mar, Barcelona Biomedical Research Park, Barcelona, Spain

Speakers

  • Jorge Reis-Filho
    The Institute of Cancer Research, London, UK
    “Triple negative breast cancer and PARP inhibition”
  • Eva González-Suárez
    IDIBELL (Instituto de Investigaciones Biomédicas de Bellvitge)-Hospital Duran i Reynals, Barcelona, Spain
    “RANKL as an anticancer target”
  • Ramon Colomer
    Centro Oncológico MD Anderson España, Madrid, Spain
    “Advances in HER2 targeting”
  • Roger Gomis
    Institute for Research in Biomedicine (IRB), Barcelona, Spain
    “Breast cancer metastasis”

11.00-11.30 Coffee Break and visit to poster session II

11.30-12.30 Invited lecture II

Chairmen

  • Alfredo Carrato

Speaker

  • Francisco Real
    Centro Nacional de Investigaciones Oncológicas CNIO / Spanish National Cancer Research Center,  Madrid, Spain
    “Bladder cancer: biology looks for employment opportunities”

12.30-14.30 Symposium VI: Lung cancer

Chairmen

  • Luis Montuenga
    (Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Pamplona)
  • Rafael Rosell 
    (Hospital Germans Trias i Pujol, Barcelona)

Speakers

  • John Field
    The Roy Castle Lung Cancer Research Programme, University of Liverpool, UK
    “Progress in risk assessment and early lung cancer screening”
  • Montserrat Sánchez-Céspedes
    IDIBELL, Barcelona
    “Molecular genetics of Non Small Cell Lung cancer”
  • Rubén Pío
    Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Pamplona
    “Complement activation and immunotherapy in Lung Cancer”
  • Rafael Rosell
    Hospital Germans Trias I Pujol, Barcelona
    “The predictive role of signalling networks involved in advanced lung cancer: translational and clinical perspectives”

12.30-14.30 Symposium VII: Paediatric cancer, sarcomas and soft tissues tumours

Chairmen

  • José Sánchez de Toledo
    Hospital Universitario Vall d'Hebron. FIRVH. Barcelona
  • Enrique de Álava
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain

Speakers

  • Rafael Peris-Bonet
    Registro Nacional Tumores Infantiles (RNTI). Valencia
    Childhood Cancer. Epidemiology in Spain
  • Soledad  Gallego-Melcon
    Hospital Universitario Vall d'Hebron.FIRVH.Barcelona
    Traslational research in Rhabdomyosarcomas
  • Cristina Meazza
    Fondazione IRCCS. Istituto Nazionale dei Tumori. Milano
    Non-Rhabdomyosarcoma Soft Tissue Sarcomas. Clinical and Therapeutic topics.
  • Enrique de Álava
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain
    Molecular biology of soft tissue sarcomas non-Rhabdomyosarcomas

14.30-16.00 Lunch and visit to poster session II

16.00-18.00 Symposium VIII: Head and neck cancer

Chairmen

  • Juan Jesús Cruz 
    Hospital Universitario de Salamanca, Salamanca
  • Juan José Grau de Castro,
    Servicio de Oncología Médica, H. Clinic i Provincial, Barcelona

Speakers

  • Atanasio Pandiella
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain
    New clinical  targets in head and neck cancer
  • Ricardo Hitt
    Hospital 12 de Octubre, Madrid
    Clinical experience of head and neck tumour treatment with monoclonal antibodies
  • José Manuel Trigo
    Hospital Universitario Virgen de la Victoria, Málaga
    Oropharynx tumours and papillomavirus infection.  Are they different entities?
  • Albert Biete
    Hospital Clínic de Barcelona. Barcelona
    What did the new radiotherapy techniques contribute  to head and neck tumour treatment?

16.00-18.00 Symposium IX: Haematological cancer

Chairmen

  • Jesús San Miguel
    (Hospital Universitario de Salamanca, Salamanca)
  • Miguel Angel Piris
    (Centro Nacional de Investigaciones Oncológicas CNIO / Spanish National Cancer Research Center, Madrid, Spain)

Speakers

  • Jordi Sierra
    Hospital Sant Pau, Barcelona
    Myeloblastic leukaemia: Towards a personalized therapy?
  • Dolors Colomer
    Hospital Clinic , Barcelona
    Chronic lymphatic leukaemia:  is targeted therapy a possibility?
  • Alberto Orfao
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain 
    Searching for the stem cell of multiple myeloma
  • Carlos Montalbán
    Hospital Ramón y Cajal, Madrid
    Marginal lymphomas in 2011

18.00-18.30 Coffee Break and visit to poster hall

18.30-19.30 ASEICA Assembly

19.30 Cocktail dinner